IgA Nephropathy Therapeutics Pipeline is Witnessing Significant Growth Due to Unavailability of Specific Treatment: P&S Intelligence
30 oct. 2018 02h35 HE
|
Prescient & Strategic Intelligence
Immunoglobulin A (IgA) Nephropathy Therapeutics - Pipeline Analysis, Clinical Trials & Results, Patents, Designations, Collaborations, Patient Size, and Epidemiology Forecast to 2025 NEW YORK,...
Promising Targets Spur the Growth of IgA Nephropathy Therapeutics Pipeline: P&S Market Research
03 avr. 2018 05h30 HE
|
P&S Market Research
NEW YORK, April 03, 2018 (GLOBE NEWSWIRE) -- According to a new research report titled “Immunoglobulin A Nephropathy Therapeutics - Pipeline Analysis, Clinical Trials & Results, Patents,...